Polysorbate 80 & POLYSORBATE 80 Excipient Use in Suspension Dosage Forms

Polysorbate 80

FDA Inactive Ingredient Details, DESCRIPTION

Suppliers

15 Listed Products, 1 Nanjing Bold Chemical, 1 Nanjing Well Pharmaceutical, 2 Actylis, 3 Gangwal Chemicals, 1 BASF, 1 Jai Radhe Sales, 6 Seppic

REGULATORY FILINGS

6 Suppliers, 6 USDMF, 3 CEP/COS

SOLUTIONS BY APPLICATIONS

10 Solubilizers, 5 Parenteral, 3 Emulsifying Agents, 3 Topical, 2 Surfactant & Foaming Agents, 2 Thickeners and Stabilizers, 2 Film Formers & Plasticizers, 1 Direct Compression, 1 Rheology Modifiers, 1 API Stability Enhancers, 1 Co-Processed Excipients

REF. STANDARDS & IMPURITIES

1 Others

1 Others

FINISHED FORMULATIONS

641 ORAL, 382 TABLET, 70 TABLET, EXTENDED RELEASE, 69 INJECTABLE, 61 INJECTION, 40 CAPSULE, 40 SUSPENSION, 35 CAPSULE, DELAYED REL PELLETS, 21 TOPICAL, 20 OPHTHALMIC, 19 NASAL, 19 SPRAY, METERED, 17 CAPSULE, DELAYED RELEASE, 16 TABLET, DELAYED RELEASE, 14 CAPSULE, EXTENDED RELEASE, 13 FOR SUSPENSION, 12 CREAM, 12 INTRAVENOUS, 12 SUSPENSION/DROPS, 11 GEL, 11 SOLUTION, 11 SOLUTION/DROPS, 10 INHALATION, 9 POWDER, 9 SUSPENSION, EXTENDED RELEASE, 7 ORAL-28, 7 VAGINAL, 5 RECTAL, 5 SUPPOSITORY, 4 BUCCAL, 4 FOR SUSPENSION, DELAYED RELEASE, 4 GUM, CHEWING, 3 EMULSION, 3 GRANULE, 3 INTRAMUSCULAR, 3 OTIC, 3 TABLET, ORALLY DISINTEGRATING, 2 CAPSULE, TABLET, CAPSULE, DELAYED REL PELLETS, 2 IV (INFUSION), 2 LOTION, 2 ORAL-21, 2 SUBCUTANEOUS, 2 TABLET, CHEWABLE, 2 VIAL, 1 AEROSOL, FOAM, 1 ENEMA, 1 FOR SOLUTION, 1 FOR SUSPENSION, EXTENDED RELEASE, 1 INJECTABLE, TABLET, 1 INTRA-ARTICULAR, 1 INTRAMUSCULAR, ORAL, 1 INTRAVENOUS, ORAL, 1 INTRAVENOUS, SUBCUTANEOUS, 1 OPHTHALMIC, OTIC, 1 POWDER, FOR INJECTION SOLUTION, LYOPHILIZED POWDER, 1 SUBCUTANEOUS LYOPHILIZED POWER, 1 SYRINGE, 1 SYRUP, 1 SYSTEM